The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Vaccination with a recombinant vaccinia virus encoding a “self” antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4+T lymphocytes
Open accessAbstract
Many human and mouse tumor antigens are normal, nonmutated tissue differentiation antigens. Consequently, immunization with these “self” antigens could induce autoimmunity. When we tried to induce immune responses to five mouse melanocyte differentiation antigens, gp100, MART-1, tyrosinase, and tyrosinase-related proteins (TRP) 1 and TRP-2, we observed striking depigmentation and melanocyte destruction only in the skin of mice inoculated with a vaccinia virus encoding mouse TRP-1. These mice rejected a lethal challenge of B16 melanoma, indicating the immune response against TRP-1 could destroy both normal and malignant melanocytes. Cytotoxic T lymphocytes specific for TRP-1 could not be detected in depigmented mice, but high titers of IgG anti-TRP-1 antibodies were present. Experiments with knockout mice revealed an absolute dependence on major histocompatibility complex class II, but not major histocompatibility complex class I, for the induction of both vitiligo and tumor protection. Together, these results suggest that the deliberate induction of self-reactivity using a recombinant viral vector can lead to tumor destruction, and that in this model, CD4+T lymphocytes are an integral part of this process. Vaccine strategies targeting tissue differentiation antigens may be valuable in cancers arising from nonessential cells and organs such as melanocytes, prostate, testis, breast, and ovary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The expanding universe of T-cell subsets: Th1, Th2 and more
Mosmann, T. R., & Sad, S. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80606-2 · Cited by 3,633
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Di Rosa, F., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,342
Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
Self-citationWalter, E. A., Greenberg, P. D., Gilbert, M. J., Finch, R. J., Watanabe, K. S., Thomas, E. D., & Riddell, S. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510193331603 · Cited by 1,771
Current Protocols in Molecular Biology
(2018) · Current Protocols in Molecular Biology · doi:10.1002/(issn)1934-3647 · Cited by 1,372
Immunity to Methylcholanthrene-Induced Sarcomas
(1957) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/18.6.769 · Cited by 1,229
Romagnani, S. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)80019-9 · Cited by 1,078
β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells
Zijlstra, M., Bix, M., Simister, N. E., Loring, J. M., Raulet, D. H., & Jaenisch, R. (1990) · Nature · doi:10.1038/344742a0 · Cited by 1,012
Junghans, R. P., & Anderson, C. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5512 · Cited by 684
Depletion of CD4 + T Cells in Major Histocompatibility Complex Class II-Deficient Mice
Grusby, M. J., Johnson, R. S., Papaioannou, V. E., & Glimcher, L. H. (1991) · Science · doi:10.1126/science.1910207 · Cited by 660
Ossendorp, F., Mengedé, E., Camps, M., Filius, R., & Melief, C. J. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.693 · Cited by 610
Tumor antigens recognized by T cells
Boon, T., Coulie, P. G., & Van den Eynde, B. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)80020-5 · Cited by 537
Overwijk, W. W., Tsung, A., Irvine, K. R., Parkhurst, M. R., Goletz, T. J., Tsung, K., Carroll, M. W., Liu, C., Moss, B., Rosenberg, S. A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.277 · Cited by 493
Self-citationIdentification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 Melanoma
Bloom, M. B., Perry-Lalley, D., Robbins, P. F., Li, Y., El-Gamil, M., Rosenberg, S. A., & Yang, J. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.453 · Cited by 401
Self-citationCompact, Synthetic, Vaccinia Virus Early/Late Promoter for Protein Expression
Chakrabarti, S., Sisler, J. R., & Moss, B. (1997) · BioTechniques · doi:10.2144/97236st07 · Cited by 389
Self-citationCancer vaccines based on the identification of genes encoding cancer regression antigens
Rosenberg, S. A. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)84664-6 · Cited by 386
Self-citationVitiligo in Patients with Melanoma: Normal Tissue Antigens Can Be Targets for Cancer Immunotherapy
Rosenberg, S. A., & White, D. E. (1996) · Journal of Immunotherapy · doi:10.1097/00002371-199601000-00009 · Cited by 333
Self-citationA second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus.
Jackson, I. J., Chambers, D. M., Tsukamoto, K., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., & Hearing, V. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05083.x · Cited by 322
Olivares-Villagómez, D., Wang, Y., & Lafaille, J. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1883 · Cited by 294
von Herrath, M. G., Yokoyama, M., Dockter, J., Oldstone, M. B., & Whitton, J. L. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1072-1079.1996 · Cited by 279
Pan, Z.-K., Ikonomidis, G., Lazenby, A., Pardoll, D., & Paterson, Y. (1995) · Nature Medicine · doi:10.1038/nm0595-471 · Cited by 237
Irvine, K. R., Rao, J. B., Rosenberg, S. A., & Restifo, N. P. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.238 · Cited by 233
Self-citationTumor immunity and autoimmunity induced by immunization with homologous DNA.
Weber, L. W., Bowne, W. B., Wolchok, J. D., Srinivasan, R., Qin, J., Moroi, Y., Clynes, R., Song, P., Lewis, J. J., & Houghton, A. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4004 · Cited by 228
Antibodies to normal human melanocytes in vitiligo.
Naughton, G. K., Eisinger, M., & Bystryn, J. C. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.1.246 · Cited by 216
A fail-safe mechanism for maintaining self-tolerance.
Guerder, S., & Matzinger, P. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.2.553 · Cited by 202
The role of tyrosinase in autoimmune vitiligo
Song, Y.-H., Connor, E., Li, Y., Zorovich, B., Balducci, P., & Maclaren, N. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91709-4 · Cited by 197
Hara, I., Takechi, Y., & Houghton, A. N. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1609 · Cited by 184
Akkaraju, S., Ho, W. Y., Leong, D., Canaan, K., Davis, M. M., & Goodnow, C. C. (1997) · Immunity · doi:10.1016/s1074-7613(00)80528-2 · Cited by 175
Naftzger, C., Takechi, Y., Kohda, H., Hara, I., Vijayasaradhi, S., & Houghton, A. N. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14809 · Cited by 160
de Keere, F. V., & Tonegawa, S. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1875 · Cited by 157
Bronte, V., Carroll, M. W., Goletz, T. J., Wang, M. L., Overwijk, W. W., Marincola, F. M., Rosenberg, S. A., Moss, B., & Restifo, N. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3183 · Cited by 153
Self-citationYagi, H., Matsumoto, M., Kunimoto, K., Kawaguchi, J., Makino, S., & Harada, M. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220931 · Cited by 149
Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes.
Barth, R. J., Bock, S. N., Mulé, J. J., & Rosenberg, S. A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.4.1531 · Cited by 144
Self-citationWhitham, R. H., Bourdette, D. N., Hashim, G. A., Herndon, R. M., Ilg, R. C., Vandenbark, A. A., & Offner, H. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.1.101 · Cited by 130
Melief, C. J. M., & Kast, W. M. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00081.x · Cited by 114
Kumar, V., Stellrecht, K. A., & Sercarz, E. E. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.5.1609 · Cited by 109
Christianson, G. J., Brooks, W., Vekasi, S., Manolfi, E. A., Niles, J., Roopenian, S. L., Roths, J. B., Rothlein, R., & Roopenian, D. C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4781 · Cited by 98
Long-lasting CD8 T cell memory in the absence of CD4 T cells or B cells.
Rosa, F. D., & Matzinger, P. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.5.2153 · Cited by 98
The tyrosinase gene family--interactions of melanogenic proteins to regulate melanogenesis.
WINDER, A. F., Kobayashi, T., Tsukamoto, K., et al. (1994) · PubMed · Cited by 90
Cited by
Adoptive immunotherapy for cancer: harnessing the T cell response
Restifo, N. P., Dudley, M. E., & Rosenberg, S. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3191 · Cited by 1,688
Self-citationDudley, M. E., Wunderlich, J. R., Yang, J. C., Sherry, R. M., Topalian, S. L., Restifo, N. P., Royal, R. E., Kammula, U., White, D. E., Mavroukakis, S. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.240 · Cited by 1,639
Self-citationA2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D., Wong, M. K. K., Huang, X., Caldwell, S., Liu, K., Smith, P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,065
van Elsas, A., Hurwitz, A. A., & Allison, J. P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.355 · Cited by 1,020
Overwijk, W. W., Theoret, M. R., Finkelstein, S. E., Surman, D. R., de Jong, L. A., Vyth-Dreese, F. A., Dellemijn, T. A., Antony, P. A., Spiess, P. J., Palmer, D. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030590 · Cited by 925
Self-citation
Metadata
- Authors
- Overwijk, W. W., Lee, D. S., Surman, D. R., Irvine, K. R., Touloukian, C. E., Chan, C.-C., Carroll, M. W., Moss, B., Rosenberg, S. A., & Restifo, N. P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-03-16
- Volume
- 96
- Issue
- 6
- Pages
- 2982-2987
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2107629538
- Cited by
- 381
- References
- 41
- FWCI
- 14.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.